9 September 2020
Following recent publication of the REMAP-CAP trial for hydrocortisone and a meta-analysis of corticosteroids, the World Health Organization (WHO) has recently issued new interim guidance recommending the use of systemic corticosteroids in severe and critical COVID-19 disease.
27 August 2020
David James tells us how he balances an acute specialty with a healthy work life balance - and how a bit of cycling helps, too!
25 August 2020
RCPCH welcomes the work NHS Digital have done to add Additional Information to over 54 million patients’ Summary Care Records in England.
26 June 2020
Ranitidine products (Brand names including Zantac®) were voluntarily withdrawn by manufacturers in October 2019, because of fears that they may contain low levels of an impurity called NMDA.
18 March 2020
The overall rates of smoking among UK adults and young people have declined in recent decades. Legislation around the consumption, sale and advertisement of cigarettes has become tighter, and wide-reaching public health campaigns have taken effect.
17 March 2020
The RCPCH/NPPG Medicines Committee has recently been informed of a severe adverse reaction in a six-month old child with anisocoria who had been administered apraclonidine 1% to help exclude Horner syndrome.
7 March 2020
A good start in life is critical for health—and this story begins before birth. The WHO states that monitoring maternal and child health during pregnancy is critical, and that smoking is one of the most important modifiable lifestyle choices during this period.
2 March 2020
The Medicines and Healthcare products Regulatory Agency (MHRA) is requesting that healthcare professionals report any suspected side effects or safety concerns with e-cigarettes and the e-liquids used for vaping to the Yellow Card Scheme.
12 February 2020
Dr Damian Roland explains why innovation is one of the four major workstreams we are considering in our Paediatrics 2040 project.
5 February 2020
Dr Mike Linney, Registrar and Chair of the Ethics Committee for RCPCH, welcomes recent guidance from NICE, but notes the urgent need for high quality, independent research on this medicine to provide the best possible care for children with complex epilepsy.